4//SEC Filing
LOBERG MICHAEL D 4
Accession 0001209191-22-051986
CIK 0001496323other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 8:11 PM ET
Size
8.2 KB
Accession
0001209191-22-051986
Insider Transaction Report
Form 4
LOBERG MICHAEL D
Director
Transactions
- Purchase
Common Stock
2022-09-29$19.62/sh+5,821$114,213→ 35,305 total(indirect: See footnote) - Award
Common Stock
2022-09-30+533→ 533 total
Holdings
- 43,143(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $19.36 to $19.80. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
- [F2]The shares are held by the Revocable Deed of Trust of Michael D. Loberg (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
- [F4]The shares are held by the Michael D. Loberg Qualified Annuity Interest Trust IX (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001233414
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 8:11 PM ET
- Size
- 8.2 KB